Form D · Biotechnology
GLO Pharma, Inc.
Carlsbad, CA · CIK 0001832546
Offering snapshot reported Sep 11, 2023 · SEC filing
- Reported sold
- $53M Offering amount: $53M
- Investors reported
- 189 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 30, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$42,500,000 → $53,000,000
- Reported investors180 → 189
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 11, 2023 | Amendment | $53,000,000 | $10,500,000vs Apr 3, 2023 | 189 | SEC filing |
| Apr 3, 2023 | Amendment | $42,500,000 | $20,500,000vs Feb 4, 2022 | 180 | SEC filing |
| Jun 13, 2022 | Amendment | $33,000,000 | $11,000,000vs Feb 4, 2022 | 116 | SEC filing |
| Feb 4, 2022 | Amendment | $22,000,000 | $13,000,000vs Sep 14, 2021 | 87 | SEC filing |
| Sep 14, 2021 | Initial | $9,000,000 | No comparison | Not reported | SEC filing |
| Nov 25, 2020 | Initial | $6,845,000 | No comparison | 20 | SEC filing |
| Nov 25, 2020 | Initial | $511,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-413342
Source: Form D, filed Sep 11, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marla Beck | Director |
| Vimla Black Gupta | Director, Executive |
| Maureen Case | Director |
| Scott Glenn | Director |
| Todd Jackson | Director |
| Jana Messersmith | Director |
| Lauren Otsuki | Director, Executive |
| Dayna Quanbeck | Director |
| Nicole Quinn | Director |
| Brent Saunders | Director |
| Fabian Seelbach | Director |
| Carol Shen | Director |
| Douglas Wall | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2810 Caribou Court #130
Carlsbad, CA, 92010
Carlsbad, CA, 92010